{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T11:26:47Z","timestamp":1789385207241,"version":"build-2803163510"},"reference-count":42,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2016,6,9]],"date-time":"2016-06-09T00:00:00Z","timestamp":1465430400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["HL103946"],"award-info":[{"award-number":["HL103946"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["HL091062"],"award-info":[{"award-number":["HL091062"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000921","name":"Donald W. Reynolds Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000921","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0157035","type":"journal-article","created":{"date-parts":[[2016,6,9]],"date-time":"2016-06-09T15:26:27Z","timestamp":1465485987000},"page":"e0157035","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":12,"title":["Serum-Based Oxylipins Are Associated with Outcomes in Primary Prevention Implantable Cardioverter Defibrillator Patients"],"prefix":"10.1371","volume":"11","author":[{"given":"Yiyi","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eliseo","family":"Guallar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Blasco-Colmenares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy C.","family":"Harms","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rob J.","family":"Vreeken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Hankemeier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gordon F.","family":"Tomaselli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2016,6,9]]},"reference":[{"issue":"6","key":"ref1","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/j.hrthm.2008.04.015","article-title":"ACC\/AHA\/HRS 2008 guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: executive summary","volume":"5","author":"AE Epstein","year":"2008","journal-title":"Heart Rhythm"},{"issue":"4","key":"ref2","doi-asserted-by":"crossref","first-page":"e29","DOI":"10.1161\/CIR.0000000000000152","article-title":"Heart disease and stroke statistics\u20142015 update: a report from the American Heart Association","volume":"131","author":"D Mozaffarian","year":"2015","journal-title":"Circulation"},{"issue":"12","key":"ref3","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1056\/NEJMoa013474","article-title":"Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction","volume":"346","author":"AJ Moss","year":"2002","journal-title":"N Engl J Med"},{"issue":"3","key":"ref4","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1056\/NEJMoa043399","article-title":"Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure","volume":"352","author":"GH Bardy","year":"2005","journal-title":"N Engl J Med"},{"issue":"22","key":"ref5","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1161\/CIRCULATIONAHA.110.976092","article-title":"Sudden cardiac death prediction and prevention: report from a National Heart, Lung, and Blood Institute and Heart Rhythm Society Workshop","volume":"122","author":"GI Fishman","year":"2010","journal-title":"Circulation"},{"issue":"9","key":"ref6","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1016\/j.jacc.2005.05.088","article-title":"Factors influencing appropriate firing of the implanted defibrillator for ventricular tachycardia\/fibrillation: findings from the Multicenter Automatic Defibrillator Implantation Trial II (MADIT-II)","volume":"46","author":"JP Singh","year":"2005","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"ref7","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.hrthm.2008.12.023","article-title":"Predictors of long-term mortality in Multicenter Automatic Defibrillator Implantation Trial II (MADIT II) patients with implantable cardioverter-defibrillators","volume":"6","author":"I Cygankiewicz","year":"2009","journal-title":"Heart Rhythm"},{"issue":"6","key":"ref8","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1161\/CIRCEP.113.001705","article-title":"Protein biomarkers identify patients unlikely to benefit from primary prevention implantable cardioverter defibrillators: findings from the Prospective Observational Study of Implantable Cardioverter Defibrillators (PROSE-ICD)","volume":"7","author":"A Cheng","year":"2014","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"7","key":"ref9","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1161\/hc3201.094151","article-title":"Circulating nonesterified fatty acid level as a predictive risk factor for sudden death in the population","volume":"104","author":"X Jouven","year":"2001","journal-title":"Circulation"},{"issue":"22","key":"ref10","doi-asserted-by":"crossref","first-page":"2595","DOI":"10.1161\/01.CIR.0000017493.03108.1C","article-title":"Prospective study of C-reactive protein, homocysteine, and plasma lipid levels as predictors of sudden cardiac death","volume":"105","author":"CM Albert","year":"2002","journal-title":"Circulation"},{"issue":"12","key":"ref11","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1161\/CIRCRESAHA.116.304691","article-title":"Mechanisms of sudden cardiac death: oxidants and metabolism","volume":"116","author":"KC Yang","year":"2015","journal-title":"Circ Res"},{"issue":"11","key":"ref12","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1038\/nrcardio.2011.138","article-title":"Metabolomics as a tool for cardiac research","volume":"8","author":"JL Griffin","year":"2011","journal-title":"Nat Rev Cardiol"},{"issue":"2","key":"ref13","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1161\/CIRCGENETICS.109.852814","article-title":"Association of a Peripheral Blood Metabolic Profile With Coronary Artery Disease and Risk of Subsequent Cardiovascular Events","volume":"3","author":"SH Shah","year":"2010","journal-title":"Circ-Cardiovasc Gene"},{"issue":"4","key":"ref14","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1038\/nm.2307","article-title":"Metabolite profiles and the risk of developing diabetes","volume":"17","author":"TJ Wang","year":"2011","journal-title":"Nat Med"},{"issue":"11","key":"ref15","doi-asserted-by":"crossref","first-page":"2618","DOI":"10.1039\/c3mb70227h","article-title":"Metabolomic identification of diagnostic plasma biomarkers in humans with chronic heart failure","volume":"9","author":"J Wang","year":"2013","journal-title":"Mol Biosyst"},{"issue":"15","key":"ref16","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1016\/j.jacc.2015.02.018","article-title":"Metabolic Disturbances Identified in Plasma Are Associated With Outcomes in Patients With Heart Failure: Diagnostic and Prognostic Value of Metabolomics","volume":"65","author":"ML Cheng","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"176","DOI":"10.3389\/fphar.2013.00176","article-title":"The emerging role of oxylipins in thrombosis and diabetes","volume":"4","author":"BE Tourdot","year":"2014","journal-title":"Front Pharmacol"},{"issue":"1","key":"ref18","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.plefa.2013.04.001","article-title":"Comparison of free serum oxylipin concentrations in hyper- vs. normolipidemic men","volume":"89","author":"JP Schuchardt","year":"2013","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"issue":"20","key":"ref19","doi-asserted-by":"crossref","first-page":"3361","DOI":"10.1007\/s00018-012-0982-9","article-title":"An eicosanoid-centric view of atherothrombotic risk factors","volume":"69","author":"S Gleim","year":"2012","journal-title":"Cell Mol Life Sci"},{"issue":"1","key":"ref20","doi-asserted-by":"crossref","first-page":"e000083","DOI":"10.1161\/JAHA.112.000083","article-title":"Prospective observational study of implantable cardioverter-defibrillators in primary prevention of sudden cardiac death: study design and cohort description","volume":"2","author":"A Cheng","year":"2013","journal-title":"J Am Heart Assoc"},{"key":"ref21","article-title":"Serum amine-based metabolites and their association with outcomes in primary prevention implantable cardioverter-defibrillator patients","author":"Y Zhang","year":"2015","journal-title":"Europace"},{"issue":"5","key":"ref22","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1007\/s00216-012-6226-x","article-title":"Quantitative profiling of oxylipins through comprehensive LC-MS\/MS analysis: application in cardiac surgery","volume":"404","author":"K Strassburg","year":"2012","journal-title":"Anal Bioanal Chem"},{"issue":"22","key":"ref23","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.1161\/01.CIR.100.22.2248","article-title":"Arrhythmias and conduction defects as presenting symptoms of fatty acid oxidation disorders in children","volume":"100","author":"D Bonnet","year":"1999","journal-title":"Circulation"},{"issue":"4","key":"ref24","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1023\/A:1005556207210","article-title":"Recognition and management of fatty acid oxidation defects: A series of 107 patients","volume":"22","author":"JM Saudubray","year":"1999","journal-title":"J Inherit Metab Dis"},{"issue":"4","key":"ref25","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.eupc.2005.02.118","article-title":"n-3 fatty acids and ventricular arrhythmias in patients with ischaemic heart disease and implantable cardioverter defibrillators","volume":"7","author":"JH Christensen","year":"2005","journal-title":"Europace"},{"issue":"2","key":"ref26","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.ahj.2010.10.032","article-title":"Effects of n-3 polyunsaturated fatty acids on malignant ventricular arrhythmias in patients with chronic heart failure and implantable cardioverter-defibrillators: A substudy of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Insufficienza Cardiaca (GISSI-HF) trial","volume":"161","author":"AA Finzi","year":"2011","journal-title":"Am Heart J"},{"issue":"15","key":"ref27","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1056\/NEJMoa012918","article-title":"Blood levels of long-chain n-3 fatty acids and the risk of sudden death","volume":"346","author":"CM Albert","year":"2002","journal-title":"New Engl J Med"},{"issue":"1","key":"ref28","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1152\/physrev.00021.2001","article-title":"P-450 metabolites of arachidonic acid in the control of cardiovascular function","volume":"82","author":"RJ Roman","year":"2002","journal-title":"Physiol Rev"},{"issue":"11","key":"ref29","doi-asserted-by":"crossref","first-page":"R1281","DOI":"10.1152\/ajpregu.00128.2013","article-title":"Human inflammatory and resolving lipid mediator responses to resistance exercise and ibuprofen treatment","volume":"305","author":"JF Markworth","year":"2013","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"issue":"1","key":"ref30","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.bbapap.2010.09.009","article-title":"Role of cytochrome P450 enzymes in the bioactivation of polyunsaturated fatty acids","volume":"1814","author":"A Konkel","year":"2011","journal-title":"Bba-Proteins Proteom"},{"issue":"1","key":"ref31","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1161\/ATVBAHA.108.171298","article-title":"Interaction Between P450 Eicosanoids and Nitric Oxide in the Control of Arterial Tone in Mice","volume":"29","author":"HC Hercule","year":"2009","journal-title":"Arterioscl Throm Vas"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1755-8794-3-5","article-title":"Insight in modulation of inflammation in response to diclofenac intervention: a human intervention study","volume":"3","author":"MJ van Erk","year":"2010","journal-title":"BMC Med Genomics"},{"issue":"1","key":"ref33","doi-asserted-by":"crossref","first-page":"L130","DOI":"10.1152\/ajplung.90436.2008","article-title":"Relaxing effects of 17(18)-EpETE on arterial and airway smooth muscles in human lung","volume":"296","author":"C Morin","year":"2009","journal-title":"Am J Physiol-Lung C"},{"issue":"6","key":"ref34","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1113\/expphysiol.2007.038166","article-title":"The vasodilator 17,18-epoxyeicosatetraenoic acid targets the pore-forming BK alpha channel subunit in rodents","volume":"92","author":"HC Hercule","year":"2007","journal-title":"Exp Physiol"},{"issue":"5","key":"ref35","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1165\/rcmb.2009-0155OC","article-title":"17,18-epoxyeicosatetraenoic acid targets PPARgamma and p38 mitogen-activated protein kinase to mediate its anti-inflammatory effects in the lung: role of soluble epoxide hydrolase","volume":"43","author":"C Morin","year":"2010","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"12","key":"ref36","doi-asserted-by":"crossref","first-page":"4109","DOI":"10.1021\/jm200132q","article-title":"17(R),18(S)-epoxyeicosatetraenoic acid, a potent eicosapentaenoic acid (EPA) derived regulator of cardiomyocyte contraction: structure-activity relationships and stable analogues","volume":"54","author":"JR Falck","year":"2011","journal-title":"J Med Chem"},{"issue":"4","key":"ref37","doi-asserted-by":"crossref","first-page":"H1311","DOI":"10.1152\/ajpheart.00380.2011","article-title":"19,20-EpDPE, a bioactive CYP450 metabolite of DHA monoacyglyceride, decreases Ca(2)(+) sensitivity in human pulmonary arteries","volume":"301","author":"C Morin","year":"2011","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"3","key":"ref38","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1152\/ajplegacy.1967.213.3.725","article-title":"Effects of prostaglandins E1, E2, A1, and F1-alpha on isolated vascular smooth muscle","volume":"213","author":"CG Strong","year":"1967","journal-title":"Am J Physiol"},{"issue":"5","key":"ref39","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1152\/ajplegacy.1968.215.5.1089","article-title":"Effect of hormones on substrate preference in isolated rat heart","volume":"215","author":"AF Willebrands","year":"1968","journal-title":"Am J Physiol"},{"issue":"3","key":"ref40","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1111\/j.1476-5381.1970.tb10359.x","article-title":"Cardiovascular effects of prostaglandins mediated by the central nervous system of the dog","volume":"39","author":"HA Lavery","year":"1970","journal-title":"Br J Pharmacol"},{"key":"ref41","first-page":"332","article-title":"The prostaglandins: pharmacological and therapeutic advances","volume":"xi","author":"MF Cuthbert","year":"1973"},{"issue":"1","key":"ref42","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1093\/jn\/120.1.36","article-title":"Dietary supplementation with oils rich in (n-3) and (n-6) fatty acids influences in vivo levels of epidermal lipoxygenase products in guinea pigs","volume":"120","author":"CC Miller","year":"1990","journal-title":"J Nutr"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0157035","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,9]],"date-time":"2019-09-09T09:13:36Z","timestamp":1568020416000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0157035"}},"subtitle":[],"editor":[{"given":"Pankaj K","family":"Singh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2016,6,9]]},"references-count":42,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2016,6,9]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0157035","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,6,9]]}}}